ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 978,51
0,55%
Dow Jones
38 140,03
-0,78%
DAX
18 496,79
0,12%
Brent Oil
82,065
-1,57%
Bitcoin
69 126,49
2,28%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Supernus Pharmaceuticals Inc (SUPN)

  7. Supernus Pharmaceuticals Inc (SUPN) Actualités

SUPN

Supernus Pharmaceuticals (SUPN)

Supernus Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SUPN
DateHeureSourceTitreSymboleSociété
23/05/202422h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SUPNSupernus Pharmaceuticals Inc
23/05/202422h05GlobeNewswire Inc.Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in EpilepsyNASDAQ:SUPNSupernus Pharmaceuticals Inc
09/05/202422h05GlobeNewswire Inc.Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant SeizuresNASDAQ:SUPNSupernus Pharmaceuticals Inc
08/05/202422h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SUPNSupernus Pharmaceuticals Inc
08/05/202422h05GlobeNewswire Inc.Supernus Announces First Quarter 2024 Financial ResultsNASDAQ:SUPNSupernus Pharmaceuticals Inc
07/05/202416h00PR Newswire (US)M8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for Qelbree® (Viloxazine XR) in Latin AmericaNASDAQ:SUPNSupernus Pharmaceuticals Inc
01/05/202414h00GlobeNewswire Inc.Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree StoryNASDAQ:SUPNSupernus Pharmaceuticals Inc
24/04/202422h05GlobeNewswire Inc.Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024NASDAQ:SUPNSupernus Pharmaceuticals Inc
08/04/202414h00GlobeNewswire Inc.Supernus Provides Regulatory Update for SPN-830NASDAQ:SUPNSupernus Pharmaceuticals Inc
06/03/202422h30GlobeNewswire Inc.Supernus to Participate in Two Upcoming Investor ConferencesNASDAQ:SUPNSupernus Pharmaceuticals Inc
29/02/202423h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
28/02/202422h30GlobeNewswire Inc.Supernus to Participate in the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:SUPNSupernus Pharmaceuticals Inc
27/02/202422h14Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SUPNSupernus Pharmaceuticals Inc
27/02/202422h05GlobeNewswire Inc.Supernus Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:SUPNSupernus Pharmaceuticals Inc
26/02/202422h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
14/02/202420h33Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SUPNSupernus Pharmaceuticals Inc
14/02/202413h06Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SUPNSupernus Pharmaceuticals Inc
13/02/202422h05GlobeNewswire Inc.Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024NASDAQ:SUPNSupernus Pharmaceuticals Inc
05/02/202414h30GlobeNewswire Inc.Supernus Wins Infringement and Validity Case on Trokendi XR® against TorrentNASDAQ:SUPNSupernus Pharmaceuticals Inc
19/12/202313h30GlobeNewswire Inc.Knight Therapeutics Enters into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree® (viloxazine) in CanadaNASDAQ:SUPNSupernus Pharmaceuticals Inc
12/12/202311h50IH Market NewsHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and MoreNASDAQ:SUPNSupernus Pharmaceuticals Inc
08/11/202322h05GlobeNewswire Inc.Supernus Announces Third Quarter 2023 Financial ResultsNASDAQ:SUPNSupernus Pharmaceuticals Inc
07/11/202322h30GlobeNewswire Inc.Supernus to Participate in the Jefferies London Healthcare ConferenceNASDAQ:SUPNSupernus Pharmaceuticals Inc
02/11/202312h00GlobeNewswire Inc.Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDANASDAQ:SUPNSupernus Pharmaceuticals Inc
25/10/202322h15GlobeNewswire Inc.Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023NASDAQ:SUPNSupernus Pharmaceuticals Inc
16/10/202323h34GlobeNewswire Inc.Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® JourneyNASDAQ:SUPNSupernus Pharmaceuticals Inc
09/10/202323h45Dow Jones NewsSupernus Resubmits NDA to FDA for Apomorphine Infusion Device to Treat Parkinson'sNASDAQ:SUPNSupernus Pharmaceuticals Inc
09/10/202322h45GlobeNewswire Inc.Supernus Resubmits NDA for SPN-830 Apomorphine Infusion DeviceNASDAQ:SUPNSupernus Pharmaceuticals Inc
27/09/202322h15GlobeNewswire Inc.Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York CityNASDAQ:SUPNSupernus Pharmaceuticals Inc
10/09/202302h00GlobeNewswire Inc.Supernus Announces New Qelbree® Data Showing Improvement in ADHD SymptomsNASDAQ:SUPNSupernus Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SUPN

Dernières Valeurs Consultées

TG
526
MongoDB
NASDAQ
IBTL
iShares iBonds Dec 2031 ...
COIN
F9ETH
Falcon 9
LSE
FN05
Inter-amer 28
EU
7357T
7357T
LSE
IM31
Imp Sw Frn23
AMEX
SCE-D
Southern California Edison
ASX
AZU
Azurn International
BOV
I1PC34
International Paper
NASDAQ
CPAYX
Integrity Dividend Summi...
TG
JJ8
ASEP Medical
NASDAQ
OST
Ostin Technology
COIN
SRCOINBTC
SRCoin
LSE
IM23
Investec Bnk 26
FX
ZARARS
ZAR vs ARS
BIT
P1PLJ7
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés